Perugia, Italy

Paride Liscio

USPTO Granted Patents = 1 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Paride Liscio: Innovator in Pharmaceutical Chemistry

Introduction

Paride Liscio is a notable inventor based in Perugia, Italy. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that can modulate specific enzymatic activities. His work is aimed at addressing various health issues related to metabolic and neurodegenerative disorders.

Latest Patents

Liscio holds a patent for "Inhibitors of alpha-amino-beta-carboxymuconic acid semialdehyde decarboxylase." This patent discloses compounds capable of modulating the activity of α-amino-β-carboxymuconic acid semialdehyde decarboxylase (ACMSD). These compounds are useful for the prevention and treatment of diseases associated with defects in NAD biosynthesis, including metabolic disorders, neurodegenerative diseases, chronic inflammatory diseases, kidney diseases, and age-related diseases. The patent also includes pharmaceutical compositions comprising these compounds and their use as a medicament.

Career Highlights

Paride Liscio is currently associated with Tes Pharma S.r.l., where he continues to innovate in the pharmaceutical sector. His research focuses on developing therapeutic solutions that can significantly improve patient outcomes in various medical conditions.

Collaborations

Liscio has collaborated with notable colleagues such as Roberto Pellicciari and Nicola Giacche. These collaborations have further enhanced the scope and impact of his research in the pharmaceutical field.

Conclusion

Paride Liscio is a distinguished inventor whose work in pharmaceutical chemistry has the potential to transform treatment options for several diseases. His innovative approach and dedication to research continue to make a significant impact in the medical community.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…